Form 8-K - Current report:
SEC Accession No. 0001213900-25-040725
Filing Date
2025-05-07
Accepted
2025-05-07 17:18:47
Documents
19
Period of Report
2025-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0241313-8k_pasithea.htm   iXBRL 8-K 43847
2 FORM OF SERIES C/D COMMON WARRANT ea024131301ex4-2_pasithea.htm EX-4.2 107817
3 FORM OF PLACEMENT AGENT WARRANT ea024131301ex4-3_pasithea.htm EX-4.3 105722
4 FORM OF SECURITIES PURCHASE AGREEMENT ea024131301ex10-1_pasithea.htm EX-10.1 235364
5 PRESS RELEASE, DATED MAY 6, 2025, ANNOUNCING THE PRICING OF THE OFFERING ea024131301ex99-1_pasithea.htm EX-99.1 10485
6 PRESS RELEASE, DATED MAY 7, 2025, ANNOUNCING THE CLOSING OF THE OFFERING ea024131301ex99-2_pasithea.htm EX-99.2 10865
  Complete submission text file 0001213900-25-040725.txt   859828

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ktta-20250506.xsd EX-101.SCH 3809
8 XBRL DEFINITION FILE ktta-20250506_def.xml EX-101.DEF 26680
9 XBRL LABEL FILE ktta-20250506_lab.xml EX-101.LAB 36818
10 XBRL PRESENTATION FILE ktta-20250506_pre.xml EX-101.PRE 25304
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0241313-8k_pasithea_htm.xml XML 5915
Mailing Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139 (702) 514-4174
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40804 | Film No.: 25922769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)